Hemp Entrepreneur Fires Back at Industry Critics, Blames Consolidation

A hemp industry veteran is pushing back against recent criticism that the sector brought regulatory crackdown on itself, arguing instead that large cannabis operators are using consumer safety as cover for market consolidation.

John Grady, founder of Slaphappy Hemp Company, published a response to recent op-ed commentary claiming hemp's regulatory troubles stem from bad actors flooding the market with unregulated products. "Something real—something built with care—is being dismantled by people who never had to love it to profit from it," Grady wrote.

The rebuttal comes as hemp-derived cannabinoid products face mounting regulatory pressure from state and federal authorities. But Grady frames the debate differently than industry critics who've blamed the sector's problems on companies selling high-potency THC products with minimal oversight.

The Corporate Angle

Grady's argument centers on what he sees as established cannabis companies using regulatory concerns as a weapon against hemp competition. The numbers tell the story: hemp-derived products have captured significant market share from traditional cannabis operators, particularly in states where adult-use marijuana remains illegal.

Market watchers note this tension has been building since the 2018 Farm Bill legalized hemp production. What started as a CBD boom evolved into a thriving market for delta-8 THC and other hemp-derived cannabinoids—products that compete directly with state-licensed cannabis sales.

The op-ed directly challenges a previous Marijuana Moment piece by Max Jackson of Cannabis Wise Guys, which argued the hemp industry "killed itself" through poor self-regulation and irresponsible product marketing. Grady sees that narrative as conveniently aligned with the interests of larger cannabis operators who want hemp products brought under the same strict—and expensive—regulatory framework they operate within.

Small Business Under Pressure

For small hemp businesses like Slaphappy, the regulatory environment represents an existential threat. State-level bans on hemp-derived cannabinoids and proposed federal restrictions could wipe out companies that lack the capital and compliance infrastructure of multi-state cannabis operators.

"These weren't bad actors," Grady argues of many hemp businesses now facing regulatory heat. "These were entrepreneurs who built something from the ground up."

The distinction matters. While critics point to gas station delta-8 gummies and irresponsible marketing as evidence the industry needs guardrails, defenders like Grady say lumping responsible operators with bad actors serves the interests of consolidation, not consumer safety.

Industry data shows hemp businesses tend to be smaller, independently owned operations compared to the increasingly corporate cannabis sector. The regulatory costs of compliance hit these companies harder—a dynamic some argue is feature, not bug, of the current regulatory push.

What Comes Next

The debate reflects broader questions about how the U.S. will ultimately regulate cannabinoids. Will hemp-derived products face the same testing, packaging, and licensing requirements as marijuana? Or will a separate regulatory pathway emerge?

Congress continues to consider hemp cannabinoid legislation, with proposals ranging from outright bans to age restrictions and potency limits. The FDA has also signaled interest in regulating hemp-derived products, though the agency has yet to establish a clear framework.

For now, the industry remains split between those who see tighter regulation as necessary consumer protection and those like Grady who view it as market manipulation by deep-pocketed competitors.

The outcome will likely determine whether the hemp industry that emerged post-2018 survives in any recognizable form—or whether it gets absorbed into the larger, more heavily regulated cannabis sector that some argue wanted to eliminate the competition all along.

---

This article is based on original reporting by www.marijuanamoment.net.